Medicines safety
General information about the safety of medicines and how it is monitored. This includes various kinds of reviews of specific medicines guidelines and monitoring by the TGA.
Latest alerts
- EVE Allylisopropylacetylurea tabletsThe TGA is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.
- Counterfeit semaglutide vialsThe TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.
- New safety warning for medicines used in arthritis and other inflammatory conditionsA safety warning has been added to a class of medicines called Janus Kinase inhibitors used for chronic inflammatory conditions.
Latest articles
- Product Information safety updates - April and May 2023Medicines Safety Update - Information for health professionals
Do you read the label every time?Sometimes it can be overwhelming, but it’s important you read the information and make good decisions about whether the product is right for you.- 2023 Seasonal Influenza VaccinesInfluenza vaccines can change from year to year as new strains of influenza virus appear. This is one reason vaccination against influenza is given every year.
Latest publications
- Pharmacovigilance Inspection Program metrics report: Jan - Dec 2021The TGA Pharmacovigilance Inspection Program (PVIP) metrics report for 2021 is now available.
- Minocycline and agranulocytosisMedicines safety review
- Aconitum alkaloids in listed medicinesThe TGA has released a report on the laboratory testing of listed medicines for Aconitum alkaloid content.